Significant Role of Dicer and miR-223 in Adipose Tissue of Polycystic Ovary Syndrome Patients

Polycystic ovary syndrome (PCOS) is a chronic metabolic disease that is associated with obesity and adipose tissue dysfunction. This study aimed to explore the roles of Dicer (an enzyme that processes primary microRNAs) and microRNAs in PCOS. Protein levels were detected by western blotting, and mRNA and microRNA levels were detected by RT-PCR. Dicer-deficient pre-adipocytes were established by lentiviral transfection, and an miR-223 mimic and miR-223 inhibitor were used to overexpress and inhibit miR-223, respectively. 3T3-L1 cells were induced to differentiate into mature adipocytes by IBMX, insulin, and dexamethasone. The degree of differentiation was determined by oil red O staining. An insulin resistance model was established by exposing mature adipocytes to excessive glucose and insulin. The protein levels of Dicer and Ago2 in adipose tissues of PCOS patients were significantly lower than those in control females. A Dicer-deficient 3T3-L1 cell model was successfully established, whose proliferation was inhibited significantly. Insulin-resistant mature adipocytes expressed significantly less Dicer protein than control cells. The differentiation of Dicer-deficient 3T3-L1 cells and their expression of miR-223 and marker genes associated with adipose differentiation were reduced significantly. Furthermore, 3T3-L1 cells showed a weaker ability to develop into mature adipocytes when miR-223 expression was inhibited. An miR-223 mimic was used to recover the differentiation block induced by Dicer deficiency. This rescued the expression of genes associated with adipose differentiation, although the differentiation block was not efficiently rescued. It is concluded that insulin resistance may contribute to the decreased levels of Dicer protein in adipose tissue of PCOS patients. This suggests that dysfunction of Dicer plays a significant role in obesity of PCOS patients. miR-223 is a key factor in Dicer-regulated adipose differentiation, and other microRNAs may be involved in the process.

[1]  H. Taylor,et al.  Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor , 2019, The Journal of physiology.

[2]  B. Lee,et al.  Hyperandrogenic Milieu Dysregulates the Expression of Insulin Signaling Factors and Glucose Transporters in the Endometrium of Patients With Polycystic Ovary Syndrome. , 2019, Reproductive sciences.

[3]  K. Suhre,et al.  Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS , 2019, Front. Endocrinol..

[4]  Minghui Zhu,et al.  Iridoids with Genipin Stem Nucleus Inhibit Lipopolysaccharide-Induced Inflammation and Oxidative Stress by Blocking the NF-κB Pathway in Polycystic Ovary Syndrome , 2017, Cellular Physiology and Biochemistry.

[5]  C. Kahn,et al.  Adipose-Derived Circulating miRNAs Regulate Gene Expression in Other Tissues , 2017, Nature.

[6]  C. Hao,et al.  Identification of altered microRNAs and mRNAs in the cumulus cells of PCOS patients: miRNA-509-3p promotes oestradiol secretion by targeting MAP3K8. , 2016, Reproduction.

[7]  Yan Chen,et al.  miR-15b-AGO2 play a critical role in HTR8/SVneo invasion and in a model of angiogenesis defects related to inflammation. , 2016, Placenta.

[8]  Minghui Zhu,et al.  Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers , 2015, Oxidative medicine and cellular longevity.

[9]  R. Cobin,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[10]  S. Hammond.  An overview of microRNAs. , 2015, Advanced drug delivery reviews.

[11]  Peter Arner,et al.  MicroRNA regulatory networks in human adipose tissue and obesity , 2015, Nature Reviews Endocrinology.

[12]  Dongzi Yang,et al.  MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. , 2015, The Journal of clinical endocrinology and metabolism.

[13]  M. Kassem,et al.  microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. , 2015, Stem cells and development.

[14]  Jian Peng,et al.  MicroRNAs: emerging roles in adipogenesis and obesity. , 2014, Cellular signalling.

[15]  M. L. Wissing,et al.  MicroRNAs Related to Polycystic Ovary Syndrome (PCOS) , 2014, Genes.

[16]  P. Spritzer.  Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[17]  M. Murri,et al.  Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression. , 2013, The Journal of clinical endocrinology and metabolism.

[18]  S. Safe,et al.  A Novel Regulator of Macrophage Activation: miR-223 in Obesity-Associated Adipose Tissue Inflammation , 2012, Circulation.

[19]  H. Shimano,et al.  Dicer has a crucial role in the early stage of adipocyte differentiation, but not in lipid synthesis, in 3T3-L1 cells. , 2012, Biochemical and biophysical research communications.

[20]  R. McGregor,et al.  microRNAs in the Regulation of Adipogenesis and Obesity , 2011, Current molecular medicine.

[21]  M. Czech,et al.  Dicer is required for the formation of white but not brown adipose tissue , 2011, Journal of cellular physiology.

[22]  A. Hirschberg.  Polycystic Ovary Syndrome, Obesity and Reproductive Implications , 2009, Women's health.

[23]  Z. Paroo,et al.  A small molecule enhances RNA interference and promotes microRNA processing , 2008, Nature Biotechnology.

[24]  W. Hager,et al.  and s , 2019, Shallow Water Hydraulics.

[25]  刘畅,et al.  Identification of altered microRNAs and mRNAs in the cumulus cells of PCOS patients: miRNA-509-3p promotes oestradiol secretion by targeting MAP3K8 , 2016 .

[26]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.